GEN1042 Safety Trial and Anti-tumor Activity in Participants With Malignant Solid Tumors
Genmab
Genmab
Akeso
National Cancer Institute (NCI)
Eisai Inc.
AstraZeneca
Merus B.V.
Novartis
GlaxoSmithKline
City of Hope Medical Center
M.D. Anderson Cancer Center
Indaptus Therapeutics, Inc
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
City of Hope Medical Center
Rottapharm Biotech
Immunitas Therapeutics
AIO-Studien-gGmbH
BeiGene
Mirati Therapeutics Inc.
Korea University Anam Hospital
TCR2 Therapeutics
Affini-T Therapeutics, Inc.
Centre Georges Francois Leclerc
First Affiliated Hospital of Chongqing Medical University
A2 Biotherapeutics Inc.
Radboud University Medical Center
Centre Georges Francois Leclerc
Erasca, Inc.
Cybrexa Therapeutics
Kahr Medical
Emory University
Bexion Pharmaceuticals, Inc.
Salubris Biotherapeutics Inc
NGM Biopharmaceuticals, Inc
MIPO Clinic
Academic and Community Cancer Research United
Elpiscience (Suzhou) Biopharma, Ltd.